Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) is a publicly traded Healthcare sector company. As of September 18, 2026, ARCT trades at $16.92 with a market cap of $443.40M and a P/E ratio of -5.25. ARCT moved +1.09% today. Year to date, ARCT is +170.88%; over the trailing twelve months it is -6.20%. Its 52-week range spans $5.50 to $24.17. Analyst consensus is moderatebuy with an average price target of $21.33. Rallies surfaces ARCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover ARCT: 0 strong buy, 5 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is moderatebuy. The average price target is $21.33.
| Metric | Value |
|---|---|
| Price | $16.92 |
| Market Cap | $443.40M |
| P/E Ratio | -5.25 |
| EPS | $-3.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.17 |
| 52-Week Low | $5.50 |
| Volume | 162.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.37M |
| Net Income | $-93.28M |
| Gross Margin | 0.00% |
8 analysts cover ARCT: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $21.33.